Skip to content
Menu

Interpace Biosciences, Inc. IDXG

Full chart Compare
Set alert

Price alert · IDXG

All alert types
6.00 USD -0.20 (-3.23%)

Regular-session close

6.00 Day range 6.05
0.806 52-week range 7.80
YTD
+387.80%
1 year
+506.06%

Revenue & Expenses

Revenue Profit Costs
Income Tax Benefit$21.21MGross Profit$24.13MCost of Revenue$14.60MGross Profit & Other Income$45.34MNet Income$24.57MSelling, General & Admin$19.40MResearch & Development$642.00KInterest Expense$168.00KOther Expenses$551.00KRevenue$38.73M

Latest period ending Dec 31, 2022 · select a line to chart its full history

IDXG annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
31.84M33.12M32.40M24.22M21.90M
18.23M18.80M10.72M8.33M11.70M
-3.84M-6.67M-26.55M-26.48M-11.11M
-21.96M-14.94M-26.45M-26.74M-12.70M
-5.18-3.61-7.32-7.25-4.52
IDXG annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
4.83M2.92M3.37M2.32M6.07M
15.98M38.43M45.68M51.54M31.13M
32.52M34.31M28.23M29.85M15.68M
15.51M9.96M3.54M5.59M0
-63.07M-42.42M-29.08M-4.48M15.45M
IDXG annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-7.69M-8.72M-13.98M-18.96M-8.67M
6.21M-315.00K-1.57M-13.95M-449.00K
3.00M8.98M16.61M29.16M-9.00K
-322.00K-315.00K-1.57M-118.00K-449.00K
1.51M-58.00K1.05M-3.75M-9.13M